LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study)

Sponsor
University Hospital, Angers
Study ID
NCT06939322
Status
Recruiting
Apply to this trial

Conditions

  • Cancer Survivor
  • Hemato-oncologic Patients
  • Pediatric Cancer

Eligibility Criteria

Sex
ALL
Age
15 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Use of the Log-AFTER software — OTHER
    The LOG-AFTER software is used for long-term follow-up care after cancer to empower patients

Study Details

Childhood cancer survivors represent a high-risk population that requires risk-based follow-up. Follow-up recommendations have been harmonized. Education and information practices regarding follow-up recommendations should be personalized, to ensure understanding by all survivors, including those with neurocognitive disorders. Individualized follow-up is necessary to detect complications that may increase morbidity and decrease quality of life, or even increase the risk of early mortality. In France, the LOG-AFTER software was developed in 2017 by university hospital of Angers and Epiconcept (approved health data host). The main differences with the European procedure concern radiotherapy information, the link with the General practitioner (GP), and the possible addition of information and/or access to therapeutic education in a video format. Indeed, there is the possibility of creating an GP account allowing to receive notifications concerning the follow-up of his patient to be scheduled, to have access to his file summary and his personalized follow-up plan, various information and blank prescription models. LOG-I is a study of the impact of the LOG-AFTER software for the "patient/GP" couple on adherence to follow-up recommendations. LOG-I is interested in all former patients with at least 3 recommendations in their personalized follow-up plan, taking into account the specific population of patients cured of a brain tumor.

Key Dates

First listed
Apr 22, 2025
Start date
Jun 6, 2025
Status verified
Jun 2025
Primary completion
Nov 6, 2026
Completion
Jun 6, 2030

Study Design

Enrollment
320 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Use of the software Log-AFTER
    Patients are monitored with the help of LOG-AFTER software. Patients are advised to report the completion of the examinations (date and overall conclusion), which allows the software to function properly. The GP is also advised to report any consultations his patient has had with him and to update the date of the examinations if his patient has not done so.
  • No Intervention: WITHOUT Log-After
    Patients are monitored without the LOG-AFTER software.

Primary Outcome Measure

PPAC adherence [ Time Frame: 3 years ]

Central Contacts

Related Studies